Cancers, Vol. 16, Pages 871: CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer

In conclusion, this study highlights that CA125 kinetics can serve as an early predictor for the progression of peritoneal metastasis during TAX/RAM treatment.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research